首页> Frontiers in immunology> Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications.

Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sang T,Kim

第一单位： Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

作者： Sang T,Kim ^[1] ; Ajay,Sheshadri ^[2] ; Vickie,Shannon ^[2] ; Dimitrios P,Kontoyiannis ^[3] ; Hagop,Kantarjian ^[4] ; Guillermo,Garcia-Manero ^[4] ; Farhad,Ravandi ^[4] ; Jin S,Im ^[5] ; Prajwal,Boddu ^[4] ; Lara,Bashoura ^[2] ; Diwakar D,Balachandran ^[2] ; Scott E,Evans ^[2] ; Saadia,Faiz ^[2] ; Wilfredo,Ruiz Vazquez ^[5] ; Margarita,Divenko ^[6] ; Rohit,Mathur ^[7] ; Samantha P,Tippen ^[8] ; Curtis,Gumbs ^[8] ; Sattva S,Neelapu ^[7] ; Aung,Naing ^[9] ; Linghua,Wang ^[8] ; Adi,Diab ^[10] ; Andrew,Futreal ^[8] ; Roza,Nurieva ^[6] ; Naval,Daver ^[4]

作者单位： Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[1] Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[2] Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[3] Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[4] Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[5] Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[6] Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[7] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[8] Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[9] Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. ^[10]

关键词 Th17/Th1 cells acute myeloid leukemia checkpoint inhibitor immune-related adverse event pneumonitis